Uncategorised - European Medical Journal

The Safety Profile of Biological Agents in Patients with Psoriasis and HIV: A Systematic Review

Patients with HIV and severe psoriasis who require biological agents are thus thought to be at increased risk of adverse events….

Clinical Practice Guideline Updates

Barbara Trautner, Baylor College of Medicine, Houston, Texas, USA, presented the inaugural clinical practice guidelines for treating…

Live Webinar: ECLS with Xenios console | December 12th 7:30 AM - 8:30 AM CET

Join us to get to know Fresenius Medical Care’s ECMO offering – a dedicated technology combining both, heart and lung support in one single platform.

Neurofilament Light Chain Levels Predict Multiple Sclerosis Disability Progression

According to new research, elevation of serum neurofilament light chain, a biomarker of neuroaxonal injury, can predict disability worsening in multiple sclerosis within 1–2 years.

Does Herpes Simplex Virus 1 Increase Risk of Alzheimer’s Disease?

New evidence suggests that herpes simplex virus 1 may be associated with an increased risk for Alzheimer’s disease, according to a systematic review of published studies.

Dr Peter Ahnesorg on why leaders must never stop learning

Peter Ahnesorg, Global Hematology Franchise Head, Roche, talks about his background in biochemistry, his hopes for the haematology space and his approach to leadership.

Hematology: where's it been and where's it going?

Discover the past and future of hematology. Uncover the challenges, advancements, and the industry’s commitment to patient well-being.

Meet GOLD’s latest catalyst – Roche’s Dr Peter Ahnesorg

Tune in for a sneak peek of GOLD’s latest Catalyst interview with Dr Peter Ahnesorg, Global Hematology Franchise Head, Roche.

A Review of Oral Fixed-Dose Sodium Phenylbutyrate and Ursodoxicoltaurine in People with Amyotrophic Lateral Sclerosis

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that is estimated to affect approximately 300,000 individuals worldwide…

Therapies to Improve Multiple Myeloma Prognosis Following Relapse

Salvage therapies have been identified in a new US study that could help patients with multiple myeloma, who have tried chimeric antigen receptor T-cell therapy that has been unsuccessful.